TriLink BioTechnologies' Financial Acquisition

TriLink BioTechnologies raised a round of funding on October 26, 2017. Investors include Maravai Life Sciences.

TriLink manufactures oligonucleotides, modified nucleoside triphosphates, mRNA and long RNA.…

Articles about TriLink BioTechnologies' Financial Acquisition: